Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

ClinicalTrials.gov ID: NCT01193608

Public ClinicalTrials.gov record NCT01193608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 6:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptive, Multiple Ascending Dose Study Of The Safety, Tolerability And Pharmacokinetics Of Aab-003 (Pf-05236812) In Subjects With Mild To Moderate Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to evaluate the safety of multiple doses of AAB-003 (PF-05236812) in patients with mild to moderate Alzheimer's Disease. Patients will receive either AAB-003 (PF-05236812) or placebo. Each patient's participation will last approximately 41 weeks.

Study identification

NCT ID
NCT01193608
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Pfizer
Industry
Enrollment
88 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2010
Primary completion
Sep 30, 2013
Completion
Sep 30, 2013
Last update posted
Feb 22, 2017

2010 – 2013

United States locations

U.S. sites
23
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Early Phase Investigational Center Escondido California 92025
Synergy Clinical Research Center of Escondido Escondido California 92025
MD Clinical Hallandale Florida 33009
Franck's Pharmacy Ocala Florida 34471
Munroe Regional Medical Center Ocala Florida 34471
Renstar Medical Research Ocala Florida 34471
Advanced Imaging of Ocala Ocala Florida 34481
Atlanta Center for Medical Research Atlanta Georgia 30308
Foers Medical Arts Pharmacy Bethesda Maryland 20814
CBH Health, LLC Rockville Maryland 20850
Borgess Medical Center Kalamazoo Michigan 49048
Borgess Research Institute Kalamazoo Michigan 49048
KNI/Southwest Michigan Imaging Center, LLC Kalamazoo Michigan 49048
Brentwood Behavioral Healthcare Flowood Mississippi 39232
Marty's Pharmacy Flowood Mississippi 39232
Precise Research Centers Flowood Mississippi 39232
Millennium Psychiatric Associates, LLC Creve Coeur Missouri 63141
DePaul Health Center St Louis Missouri 63044
Memory Enhancement Center of America, Inc. Eatontown New Jersey 07724
Pharmacare USA Edison New Jersey 08837
Central Jersey Radiology Oakhurst New Jersey 07755
Belmont Center for Comprehensive Treatment Philadelphia Pennsylvania 19131-1689
Albert Einstein Medical Center Philadelphia Pennsylvania 19141

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01193608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2017 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01193608 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →